Bragg Financial Advisors’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,750
Closed -$223K 320
2024
Q1
$223K Sell
15,750
-54,884
-78% -$828K 0.01% 313
2023
Q4
$1.22M Sell
70,634
-81,949
-54% -$1.25M 0.06% 190
2023
Q3
$2.33M Buy
152,583
+12,067
+9% +$214K 0.12% 150
2023
Q2
$2.65M Buy
140,516
+19,834
+16% +$383K 0.15% 145
2023
Q1
$2.33M Buy
120,682
+18,229
+18% +$367K 0.14% 148
2022
Q4
$1.97M Buy
102,453
+12,079
+13% +$237K 0.12% 157
2022
Q3
$1.88M Buy
90,374
+7,518
+9% +$191K 0.13% 153
2022
Q2
$2.31M Buy
82,856
+8,418
+11% +$250K 0.15% 140
2022
Q1
$2.33M Buy
74,438
+17,788
+31% +$560K 0.14% 145
2021
Q4
$1.68M Hold
56,650
0.11% 155
2021
Q3
$1.68M Buy
56,650
+8,946
+19% +$261K 0.11% 155
2021
Q2
$1.27M Buy
47,704
+11,026
+30% +$312K 0.08% 173
2021
Q1
$1.01M Buy
36,678
+4,288
+13% +$120K 0.07% 180
2020
Q4
$892K Buy
32,390
+8,613
+36% +$227K 0.08% 167
2020
Q3
$618K Buy
23,777
+8,257
+53% +$217K 0.06% 178
2020
Q2
$412K Buy
+15,520
New +$398K 0.05% 198

Other funds holding HR

Bragg Financial Advisors's HR Position: Q2 2024 in Review

Bragg Financial Advisors sold out of Healthcare Realty (HR) in Q2 2024, closing a stake of 15,750 shares — an estimated $223K sold.

Bragg Financial Advisors first reported a position in HR in Q2 2020 and held it in 16 quarters. The position peaked at $2.65M in Q2 2023. 392 funds tracked by Wall St. Rank hold HR as of Q2 2024.

  • Bragg Financial Advisors reported no remaining Healthcare Realty position as of Q2 2024 after selling out during the quarter.
  • Bragg Financial Advisors sold 15,750 Healthcare Realty shares in Q2 2024, an estimated $223K.
  • Bragg Financial Advisors first reported a position in Healthcare Realty in Q2 2020 and held it in 16 quarters.
  • Bragg Financial Advisors's Healthcare Realty position peaked at $2.65M in Q2 2023.
  • 392 funds tracked by Wall St. Rank held Healthcare Realty as of Q2 2024.

Based on Bragg Financial Advisors's 13F filing for Q2 2024, filed 15 Aug 2024.